feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

US GDP grew 4.3%

trending

Earthquake swarm rattles San Ramon

trending

Arunachal Pradesh: First Indian Sunrise

trending

Rocket Lab wins $816 million

trending

ServiceNow buys Armis for $7.75B

trending

Rams stars for 2026 Pro Bowl

trending

Republic Services director buys shares

trending

Mandhana achieves T20I milestone

trending

DR Congo faces Benin

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / WHO: CD4 Tests Key for Advanced HIV Detection

WHO: CD4 Tests Key for Advanced HIV Detection

23 Dec

•

Summary

  • WHO recommends CD4 testing to identify advanced HIV disease.
  • Advanced HIV disease is a major cause of AIDS-related deaths globally.
  • New guidelines focus on early detection and rapid ART initiation.
WHO: CD4 Tests Key for Advanced HIV Detection

The World Health Organization (WHO) has released new 2025 guidelines emphasizing the critical role of CD4 testing in identifying advanced HIV disease. This recommendation is a significant step towards reducing AIDS-related deaths, which are largely attributed to this severe stage of HIV infection. The guidelines define advanced HIV disease as a CD4 cell count below 200 cells/mm3 in adults and children aged five and older.

For children under five, advanced HIV disease is presumed unless they have received ART for over a year and are clinically stable. In settings where CD4 testing is unavailable, WHO clinical staging will be used. The guidelines also detail specific scenarios for CD4 testing, including those initiating or reinitiating ART, experiencing treatment failure, or hospitalization.

Beyond diagnosis, the guidelines advocate for interventions to support hospital discharge transitions and reduce readmissions, such as goal setting and transitional care planning. For Kaposi's sarcoma, paclitaxel or pegylated liposomal doxorubicin are suggested. These updated recommendations aim to improve treatment outcomes and progress towards global HIV elimination targets.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The WHO strongly recommends CD4 testing as the preferred method to identify advanced HIV disease.
The WHO defines advanced HIV disease as a CD4 cell count less than 200 cells/mm3 in adults and children five years and older.
The guidelines focus on early detection, rapid ART initiation, and optimized clinical management to reduce morbidity and mortality.

Read more news on

Healthside-arrowWorld Health Organizationside-arrow

You may also like

ACS Embraces Home HPV Tests for Cervical Cancer

17 Dec • 48 reads

article image

WHO Chief Eyes Pandemic Treaty Annex by 2026

11 Dec • 60 reads

HIV Cure Closer? Science Explores Functional Treatment

4 Dec • 120 reads

article image

India Beats HIV: New Infections Drop Dramatically

4 Dec • 102 reads

article image

Global HIV Fight Threatened by US Funding Cuts

2 Dec • 113 reads

article image